Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Assets (2020 - 2025)

Revolution Medicines has reported Return on Assets over the past 6 years, most recently at 0.49% for Q4 2025.

  • Quarterly results put Return on Assets at 0.49% for Q4 2025, down 49.0% from a year ago — trailing twelve months through Dec 2025 was 0.49% (down 49.0% YoY), and the annual figure for FY2025 was 0.46%, down 46.0%.
  • Return on Assets for Q4 2025 was 0.49% at Revolution Medicines, down from 0.15% in the prior quarter.
  • Over the last five years, Return on Assets for RVMD hit a ceiling of 0.0% in Q4 2024 and a floor of 0.49% in Q4 2025.
  • Median Return on Assets over the past 5 years was 0.28% (2023), compared with a mean of 0.24%.
  • Biggest five-year swings in Return on Assets: rose 29bps in 2024 and later plummeted -49bps in 2025.
  • Revolution Medicines' Return on Assets stood at 0.25% in 2021, then decreased by -20bps to 0.3% in 2022, then increased by 5bps to 0.29% in 2023, then surged by 100bps to 0.0% in 2024, then plummeted by -3032117bps to 0.49% in 2025.
  • The last three reported values for Return on Assets were 0.49% (Q4 2025), 0.15% (Q3 2025), and 0.09% (Q2 2025) per Business Quant data.